Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Alzheimer Disease

This gross habit could reduce your risk of alzheimer’s by 37%, according to experts

Certain amounts of hydrogen sulfide can help protect aging brains from Alzheimer’s disease, according to a 2021 study

The Independent UK

Weight loss jab could be used to slow progression of Alzheimer’s disease in major breakthrough

Liraglutide, sold under the brand name Saxenda, is already prescribed on the NHS as a weight loss medication

The Independent UK

Obesity speeds up the development of Alzheimer’s disease, study reveals

Obesity is associated with an increase in dementia risk and researchers can now see that it speeds up the development of Alzheimer’s in particular

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Scientists reveal how many steps you need to walk daily to reduce Alzheimer’s risk

A new 14-year study is one of the first to explore the relationship between activity and key markers of the disease

The Independent UK

Walking for more than 5,000 steps per day may reduce Alzheimer’s risk – study

There was a slowing in the build-up of a protein called tau, which becomes abnormal in Alzheimer’s.

Evening Standard

2 ‘Strong Buy’ Stocks That Wall Street Believes Can Soar 360% to 780%

These two growth stocks are attractive for investors seeking big upside in exchange for higher risk.

Barchart

NHS risks missing ‘new era’ of Alzheimer’s treatment without major reforms, experts warn

A new ‘medical revolution’ in treating Alzheimer’s disease is coming, a leading professor says

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

NHS ‘not ready’ for new era of Alzheimer’s diagnosis and treatment, experts say

It comes as a series of papers by 40 experts said a ‘concerted societal effort’ is needed to ensure patients benefit fully from scientific advances.

Evening Standard

World Alzheimer's Day: Is France's once world-renowned care falling behind?

France was once a pioneer of Alzheimer's care, but as the number of sufferers continues to rise and budgets are cut, the country is now struggling to tackle what is one of the world's most pressing public health crises.

Radio France Internationale

SHIELD: A simple, memorable model to help prevent Alzheimer’s disease and dementia

Alzheimer’s disease (AD) is on track to become one of the defining public health challenges of our time. Every three seconds, somewhere in the world, someone is diagnosed with dementia, and it’s usually Alzheimer’s disease.

The Conversation

Scientists design a new digital test to diagnose Alzheimer’s

Experts believe new test could give doctors a chance to identify potential dementia cases earlier

The Independent UK

NHS to trial revolutionary blood test that could speed up Alzheimer’s diagnosis

Only two-thirds of people with dementia have a diagnosis, despite it being the leading cause of death in UK

The Independent UK

British patients trial major new blood test for Alzheimer’s disease

Alzheimer’s disease is the most common cause of dementia and linked to the build-up of two key proteins in the brain called amyloid and tau.

Evening Standard

Air pollution has been tied to Alzheimer’s disease. Here’s what you need to know

‘Air pollution doesn’t just increase the risk of dementia — it actually makes Alzheimer’s disease worse,’ Dr. Edward Lee says

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation

Alzheimer’s disease: new three-minute test can spot memory issues – here’s how it works and what it can tell you

A new test could help to diagnose memory issues associated with Alzheimer’s disease in as little as three minutes. According to recently published findings the test, called the Fastball EEG test, may one day help doctors flag people who need further checks for Alzheimer’s disease without the need for unnecessary…

The Independent UK

5 early signs of Alzheimer’s you shouldn’t ignore

It’s crucial to consult a doctor if you notice these symptoms are interfering with daily life

The Guardian - UK

Three-minute test helps identify people at greater risk of Alzheimer’s, trial finds

Test detects memory problems linked to Alzheimer’s long before typical diagnosis, raising possibility of earlier drug intervention

The Independent UK

Researchers say clinical trials are needed to determine the biological trajectory of Alzheimer’s disease

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

Women with Alzheimer’s have unusually low omega fatty acid levels, study finds

Analysis of blood samples finds women with the disease have 20% lower levels, a pattern not seen in men

Evening Standard

Cheap supplement may protect against Alzheimer’s in women

People can get omega fatty acids as a supplement or by eating salmon, mackerel or sardines.

The Independent UK

The mineral that could protect against Alzheimer’s disease

For nearly a decade, scientists from Harvard University have also been uncovering lithium’s unexpected importance in the brain

The Independent UK

The vaccine that could lower the risk of dementia by 20 per cent

A new study could change the way we understand and treat dementia and other degenerative disorders of the brain

The Conversation

Vaccines hold tantalizing promise in the fight against dementia

Over the past two centuries, vaccines have been critical for preventing infectious diseases. The World Health Organization estimates that vaccination prevents between 3 million and 5 million deaths annually from diseases like diphtheria, tetanus, influenza, measles and, more recently, COVID-19.

Benzinga

Eli Lilly's Early Alzheimer's Drug Recommended For Approval By European Drug Regulator's Panel

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion on Friday recommending Eli Lilly and Co.’s (NYSE:LLY) donanemab for early symptomatic Alzheimer’s disease in adults with confirmed amyloid pathology who are apolipoprotein E ε4 (ApoE4) heterozygotes or non-carriers.

The Independent UK

Blood tests could reveal early signs of Alzheimer’s disease, research suggests

Researchers say the findings provide new insights into possible early indicators of Alzheimer’s disease

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the World Health Organization

Alzheimer Research UK

Johns Hopkins Medicine

25 stories

The European Medicines Agency

21 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.